BDX

Manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products

Becton, Dickinson & Co. is a global medical technology company.

The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

The company operates through three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences.

The BD Medical segment produces medical devices that are used in a wide range of healthcare settings.

This segment product include needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes.

The BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect a broad range of infectious diseases, healthcare-associated infections and cancers.

This segment products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; and plated media.

The BD Biosciences segment produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes.

This segment product include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing.

Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

http://de.4-traders.com/BECTON-DICKINSON-AND-CO-11801/unternehmen/

http://www.bd.com/investors/

 

http://www.bd.com/_Images/BD_FY2015_Q3_Presentation_tcm49-20675.pdf  

Hallo,

Becton steigert wieder die Dividende:
http://www.finanzen.net/nachricht/aktien/...-44-Jahr-in-Folge-4622607

Ich habe mich auch mal ausführlich mit Becton beschäftigt, finde es ist ein super langfrist Investment und man sollte hier bei Kursschwäche immer nachkaufen.

http://finance-engineer.de/...n-das-dividendendepot-becton-dickinson/

Gruß Ralph  

Interessanter Wert, dennoch so Ruhig hier?  

ich hab Becton de facto auf der Watchlist - dauert aber noch was (muss sparen) - Sch....  

http://www.4-traders.com/...n-and-beats-Street-4Q-forecasts-23329995/  

http://seekingalpha.com/pr/...unces-results-2017-first-fiscal-quarter  

http://www.handelsblatt.com/unternehmen/industrie/...he/19706798.html

http://bd.com/_Images/BD-Bard-presentation.pdf  

http://phx.corporate-ir.net/...&p=irol-newsArticle&ID=2268583


http://www.bd.com/_Images/BD_FY2017_Q2_Presentation.pdf  

http://www.4-traders.com/...n-Dickinson-and-reports-3Q-loss-24875603/  

http://www.4-traders.com/...uarter-And-Full-Year-Provides-F-25419722/  

Becton Dickinson and (NYSE:BDX) reported earnings of $2.48 per share beating Walls Streets expectations.

02/06/2018 | 09:32am EST
Becton Dickinson and (NYSE:BDX) reported Q1 2018 earnings this Morning, coming in at $2.48 per share, beating Wall Street’s estimates of $2.41 per Share. Revenue for the quarter came in at $3.08 billion beating analyst estimates of $3.05 billionRecent Insider Trading for Becton Dickinson and (NYSE:BDX)

Weiter hier:  http://www.4-traders.com/...beating-Walls-Streets-expectati-25939869/  

http://www.4-traders.com/...son-Fiscal-2Q-Earnings-Snapshot-26482085/  

Vielen Dank das du hier immer fleißig die Links postest!

Gerne würde mich aber deine persönliche Meinung zum Unternehmen interessieren. Ich bin bereits investiert aber leider viel zu spät und erst bei 130€ eingestiegen...derzeit überlege ich aufzustocken da ich 100% von dem Unternehmen überzeugt bin. Die Übernahme C.R.Bard wird Unmengen an Geld einspülen und die Dividende wird sicher wieder kräftiger erhöht werden .

Wo siehst du den Burggraben bei BDX?
Wie siehst du die nahe/ferne Zukunft (Demografischer Wandel und Auswirkungen)?
Wie siehst du BDX im vergleich zur Konkurrenz aufgestellt?  

 

https://www.marketscreener.com/...scal-4Q-Earnings-Snapshot-27554369/

For the fiscal year 2019, the company now expects sales growth of 8.5% to 9.5%. It also guides adjusted diluted earnings to be between $12.05 and $12.15 a share.

https://www.marketscreener.com/...oss-Provides-FY19-Outlook-27554522/  

https://www.streetinsider.com/Corporate+News//...idance/15078928.html  

https://www.marketscreener.com/...scal-2Q-Earnings-Snapshot-28566153/  

https://www.marketscreener.com/...scal-4Q-Earnings-Snapshot-29517361/

FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Tuesday reported fiscal fourth-quarter net income of $150 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had profit of 41 cents. Earnings, adjusted for one-time gains and costs, came to $3.31 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $3.30 per share.
The medical device manufacturer posted revenue of $4.58 billion in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $4.57 billion.
For the year, the company reported profit of $1.22 billion, or $3.89 per share. Revenue was reported as $17.29 billion.
Becton Dickinson expects full-year earnings in the range of $12.50 to $12.65 per share.
Becton Dickinson shares have increased 16% since the beginning of the year, while the Standard & Poor's 500 index has risen 23%. The stock has risen 11% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BDX at

 

 

https://www.marketscreener.com/...scal-1Q-Earnings-Snapshot-29950888/

Becton Dickinson: Fiscal 1Q Earnings Snapshot


02/06/2020 | 06:09am EST
FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Thursday reported fiscal first-quarter net income of $278 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had profit of 87 cents. Earnings, adjusted for non-recurring costs and restructuring costs, came to $2.65 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $2.63 per share.
The medical device manufacturer posted revenue of $4.22 billion in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $4.17 billion.
Becton Dickinson expects full-year earnings in the range of $11.90 to $12.10 per share.  

Ich bin dann hier mal long investiert....  

Gordon Reid discusses Becton Dickinson

https://www.bnnbloomberg.ca/video/...scusses-becton-dickinson~2045928  

Jennifer Radman discusses Becton Dickinson

https://www.bnnbloomberg.ca/video/...scusses-becton-dickinson~2050873  

Paul Harris discusses Becton Dickinson

https://www.bnnbloomberg.ca/video/...scusses-becton-dickinson~2063107